Last updated: May 17, 2024
Sponsor: Boston Children's Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Vision Loss
Williams Syndrome
Eye Disorders/infections
Treatment
whole genome sequencing or whole exome sequencing
Clinical Study ID
NCT04770519
IRB-P00036313
R01EY032539
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Member of a family with at least 3 biological relatives with strabismus. (Bothaffected and non-affected family members will be enrolled).
OR
- Member of a family with at least 1 individual with infantile esotropia. (Bothaffected and non-affected family members will be enrolled).
OR
- Member of a family with at least 1 individual with infantile nystagmus. (Bothaffected and non-affected family members will be enrolled).
Exclusion
Exclusion Criteria:
- paralytic strabismus in affected family members
Study Design
Total Participants: 400
Treatment Group(s): 1
Primary Treatment: whole genome sequencing or whole exome sequencing
Phase:
Study Start date:
September 03, 2021
Estimated Completion Date:
December 31, 2026
Connect with a study center
Boston Children's Hospital
Boston, Massachusetts 02115
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.